refractory APL

Related by string. * Refractory : relapsed refractory multiple myeloma . refractory Hodgkin lymphoma . hormone refractory prostate cancer . relapsed refractory AML . refractory anemia . rituximab refractory follicular . refractory multiple myeloma / Apl . apl . APLS . APLD . Apling . APLs : Texas panhandle APL . CheckFree APL . BPL APL . APL BPL . Appalachia APL . JHU APL * refractory APL following *

Related by context. Frequent words. (Click for all words.) 68 Jevtana 67 tamibarotene 67 Phenoptin 66 Amrubicin 66 refractory PTCL 65 refractory Hodgkin lymphoma 65 alvimopan 65 relapsed refractory multiple myeloma 64 metastatic renal cell carcinoma 64 Torisel 64 Folotyn 64 relapsed multiple myeloma 64 CR# vcMMAE 64 refractory multiple myeloma 63 chronic angina 63 biologic therapy 63 Cethrin 63 diabetic neuropathic pain 63 Nexavar ® 63 Irinotecan 62 axitinib 62 HER2 positive metastatic breast 62 pralatrexate 62 vandetanib 62 ocrelizumab 62 TORISEL 62 prGCD 62 PREOS 62 Asentar 62 PhosLo 62 PegIntron 62 registrational 62 lymphoma CTCL 62 ridaforolimus 61 Avastin bevacizumab 61 Pivotal Phase III 61 glufosfamide 61 L MTP PE 61 Alemtuzumab 61 Icatibant 61 Stedivaze 61 Hycamtin 61 orphan designation 61 Pirfenidone 61 Clolar 61 gastrointestinal stromal tumors 61 orphan medicinal product 61 bazedoxifene 61 methylnaltrexone 61 temsirolimus 61 HRPC 61 hyperuricemia 61 Taxotere ® 61 aflibercept 61 Genentech Roche 60 tanespimycin 60 Cladribine Tablets 60 relapsing MS 60 NUVIGIL 60 TREANDA 60 romiplostim 60 BEMA Buprenorphine 60 PEG INTRON 60 KNS # 60 Relistor 60 PROMACTA 60 clofarabine 60 Allovectin 7 R 60 Diamyd ® 60 thymalfasin 60 dacarbazine 60 teduglutide 60 Everolimus 60 ELND# 60 CoFactor 60 ponatinib 60 valopicitabine 60 HGS ETR1 60 Kuvan 60 secondary hyperparathyroidism 60 interferon beta 1a 60 Cimzia R 60 Treanda 60 Increlex 60 MOZOBIL 60 eltrombopag 60 maribavir 60 Phase IIa trial 60 ofatumumab 60 romidepsin 60 confirmatory Phase III 60 FUSILEV 60 Desmoteplase 60 ocular hypertension 60 cutaneous T cell 59 refractory peripheral T 59 Phase 2b trial 59 Phase 2b study 59 chronic HCV 59 Renvela 59 pazopanib

Back to home page